In recent research, AD symptoms were ameliorated by topical treatment of specific NF-κB inhibitor (dehydroxymethylepoxyquinomicin) in chemical irritants plus horny layer removing-induced AD murine model [44]. This evidence concerns the gene NFKB1 and Alzheimer disease.